Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.
Levothyroxine .025 mg Tablet, 1 tablet — NDC 87448-1502-3 (Billing 87448-1502-03)
by Northwestern Memorial HealthCare · 1 TABLET in 1 POUCH
This is a package of 1 tablet of Levothyroxine .025 mg Tablet from Northwestern Memorial HealthCare, no longer marketed (first marketed Jan 2019), no longer in the FDA NDC Directory. It is this product's only package size.
NDC 87448-1502-03
🏷️ FDA NDC (as labeled)
87448-1502-3
billing pads the package segment with a zero
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
NDC database record
One package, one record: these facts belong to NDC 87448-1502-3 alone.
- Record
- FDA NDC Directory package listing · Human prescription drug
- Code segments
- 87448 labeler · 1502 product · 3 package
- Package marketed since
- Mar 20, 2019
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2027
- Barcode (UPC-A, from the NDC)
- 3 8744815023 9
- FDA record last changed
- Jul 24, 2026
⚠️
Excluded from the active FDA NDC Directory.
FDA inactivated this product’s listing record, so it is excluded from the active NDC Directory. The listing was last certified through Dec 2027. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory.
Search the FDA NDC Directory ↗
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
87448-1502-3
Product NDC
87448-1502
11-digit billing NDC
87448150203
RxCUI
966220
UNII
9J765S329G
Application #
ANDA209713
SPL Set ID
51dee8fe-25c4-ad9f-e063-6294a90a04bc
Established class (EPC)
l-Thyroxine
Chemical class
Thyroxine
DEA schedule
Non-controlled
Marketing category
ANDA
Marketing status
Discontinued
FDA listing status
Inactivated by FDA (certified through Dec 2027)
Marketing start
2019-01-18
Route
ORAL
Dosage form
TABLET
Substance
LEVOTHYROXINE SODIUM
TE code (Orange Book)
AB1,AB2,AB3 · RLD · RS
Quick answers
- RxCUI (RxNorm): 966220
Why two NDCs?
The FDA registers this code as 87448-1502-3 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 87448-1502-03. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- FDA label on DailyMed · label index refreshed Oct 8, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 8, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 8, 2026
RxNorm drug class
This medicine belongs to the l-Thyroxine class.
Pharmacologic class
l-Thyroxine
Drug family (ATC)
Thyroid hormones
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
- RxClass (NLM) · catalog refreshed Oct 8, 2026
Clinical
📗 Our plain-language guide HelloPharmacist
- It replaces thyroid hormone when your thyroid doesn’t make enough, a condition called hypothyroidism. Oral forms are also used with surgery and radioiodine for certain thyroid canc...
- Oral forms are usually taken once a day on an empty stomach, about 15 to 60 minutes before breakfast, depending on the product. Keep calcium, iron and antacids at least 4 hours awa...
- Full effect may take 4 to 6 weeks. Your doctor will check TSH and/or T4 blood tests to adjust your dose.
- No. It doesn’t cause weight loss at normal doses if your thyroid is normal. Larger doses can be seriously toxic.
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Levothyroxine — tap one for details:
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 8, 2026
- FDA label on DailyMed · label index refreshed Oct 8, 2026
💬 Questions about Levothyroxine?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · Q2 2026 | $0.1283 | $0.13 / 1 tablet |
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 9, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 87448-1502-03 You're viewing this Main listing | 1 TABLET in 1 POUCH | 2019-03-20 | — | Inactivated by FDA |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium 25 ug 00378-1800-10 | Mylan | 1000 tablets | $0.035 | AB1,AB2,AB3,AB4 | Availability likely | — |
| Levothyroxine Sodium 25 ug 00527-3280-43 | Lannett | 1000 tablets | $0.035 | AB1,AB2,AB3 | Availability likely | — |
| Levothyroxine Sodium .025 mg 00904-6949-61 | Major | 100 tablets | $0.035 | AB1,AB2,AB3 | Availability likely | — |
| Levothyroxine sodium 25 ug 16729-0447-15 | Accord | 90 tablets | $0.035 | AB1,AB2,AB3,AB4 | Availability likely | — |
| Levothyroxine Sodium 25 ug 33342-0393-10 | Macleods | 90 tablets | $0.035 | AB1,AB2,AB3,AB4 | Availability likely | — |
| levothyroxine sodium 25 ug 47781-0640-10 | Alvogen, | 1000 tablets | $0.035 | AB1,AB2,AB3,AB4 | Availability likely | — |
| Levothyroxine Sodium 25 ug 51079-0444-20 | Mylan | 100 tablets | $0.035 | AB1,AB2,AB3,AB4 | Availability likely | — |
| Levothyroxine Sodium .025 mg 60687-0453-01 | American | 100 tablets | $0.035 | AB1,AB2,AB3 | Availability likely | — |
| Levothyroxine Sodium .025 mg 68180-0965-01 | Lupin | 100 tablets | $0.035 | AB1,AB2,AB3 | Availability likely | — |
| Levothyroxine Sodium .025 mg 69238-1830-01 | Amneal | 100 tablets | $0.035 | AB1,AB2,AB3 | Availability likely | — |
| Levothyroxine Sodium 25 ug 72603-0660-01 | NorthStar | 90 tablets | $0.035 | AB1,AB2,AB3,AB4 | Availability likely | — |
| Euthyrox 25 ug 72305-0025-30 | Provell | 30 tablets | $0.270 | — | Discontinued | — |
| Levoxyl 25 ug 60793-0850-01 | Pfizer | 100 tablets | $0.753 | AB1,AB3 | Availability likely | — |
| Synthroid 25 ug 00074-4341-19 | AbbVie | 1000 tablets | $1.659 | AB1,AB2 | Availability likely | — |
| Unithroid 25 ug 60846-0801-01 | Amneal | 100 tablets | $4.183 | AB1,AB2,AB3 | Availability likely | — |
| Levothyroxine sodium 25 ug 00480-8682-01 | Teva | 100 tablets | — | AB1,AB2,AB3,AB4 | Discontinued | — |
| Levothyroxine Sodium .025 mg 00615-8573-05 | NCS | 15 tablets | — | AB1,AB2,AB3 | FDA listed | — |
| Levothyroxine Sodium .025 mg 31722-0284-01 | Camber | 100 tablets | — | AB4 | FDA listed | — |
| Levothyroxine Sodium .025 mg 50090-4947-00 | A-S | 30 tablets | — | AB1,AB2,AB3 | FDA listed | — |
| Levothyroxine sodium 25 ug 50090-6116-00 | A-S | 30 tablets | — | AB1,AB2,AB3,AB4 | FDA listed | — |
| Levothyroxine Sodium .025 mg 50090-7071-00 | A-S | 90 tablets | — | AB1,AB2,AB3 | FDA listed | — |
| Levothyroxine sodium 25 ug 50090-7860-00 | A-S | 90 tablets | — | AB1,AB2,AB3,AB4 | FDA listed | — |
| Levothyroxine Sodium 25 ug 50090-7909-00 | A-S | 30 tablets | — | AB1,AB2,AB3,AB4 | FDA listed | — |
| Levothyroxine Sodium 25 ug 50090-7910-00 | A-S | 90 tablets | — | AB1,AB2,AB3,AB4 | FDA listed | — |
| Levothyroxine Sodium 25 ug 51655-0846-52 | Northwind | 30 tablets | — | AB1,AB2,AB3 | FDA listed | — |
| Levothyroxine Sodium .025 mg 51655-0985-52 | Northwind | 30 tablets | — | AB1,AB2,AB3 | FDA listed | — |
| Levothyroxine Sodium .025 mg 55154-3558-00 | Cardinal | 10 tablets | — | AB1,AB2,AB3 | FDA listed | — |
| Levothyroxine Sodium 25 ug 55154-5362-00 | Cardinal | 10 tablets | — | AB1,AB2,AB3,AB4 | FDA listed | — |
| levothyroxine sodium 25 ug 63629-8711-01 | Bryant | 1000 tablets | — | AB1,AB2,AB3,AB4 | FDA listed | — |
| Levothyroxine Sodium .025 mg 67046-0828-03 | Coupler | 30 tablets | — | AB1,AB2,AB3 | FDA listed | — |
| Levothyroxine Sodium .025 mg 68071-3956-09 | NuCare | 90 tablets | — | AB1,AB2,AB3 | FDA listed | — |
| Levothyroxine sodium 25 ug 68788-7969-03 | Preferred | 30 tablets | — | AB1,AB2,AB3,AB4 | FDA listed | — |
| levothyroxine sodium 25 ug 68788-8648-03 | Preferred | 30 tablets | — | AB1,AB2,AB3,AB4 | FDA listed | — |
| Levothyroxine sodium 25 ug 70518-4400-00 | REMEDYREPACK | 90 tablets | — | AB1,AB2,AB3,AB4 | FDA listed | — |
| Levothyroxine Sodium .025 mg 71205-0221-30 | Proficient | 30 tablets | — | AB1,AB2,AB3 | FDA listed | — |
| Levothyroxine Sodium 25 ug 71205-0512-30 | Proficient | 30 tablets | — | AB1,AB2,AB3 | FDA listed | — |
| levothyroxine sodium 25 ug 71335-1447-01 | Bryant | 30 tablets | — | AB1,AB2,AB3,AB4 | FDA listed | — |
| Levothyroxine sodium 25 ug 71335-1881-01 | Bryant | 30 tablets | — | AB1,AB2,AB3,AB4 | FDA listed | — |
| levothyroxine sodium 25 ug 71335-2287-01 | Bryant | 1000 tablets | — | AB1,AB2,AB3,AB4 | FDA listed | — |
| Levothyroxine Sodium .025 mg 71335-2549-01 | Bryant | 30 tablets | — | AB1,AB2,AB3 | FDA listed | — |
| levothyroxine sodium 25 ug 72162-1458-00 | Bryant | 1000 tablets | — | AB1,AB2,AB3,AB4 | FDA listed | — |
| Levothyroxine Sodium 25 ug 72189-0174-30 | DIRECT | 30 tablets | — | AB1,AB2,AB3,AB4 | FDA listed | — |
| Levothyroxine Sodium .025 mg 72865-0236-10 | XLCare | 1000 tablets | — | AB4 | FDA listed | — |
| Levothyroxine sodium 25 ug 82804-0168-30 | Proficient | 30 tablets | — | AB1,AB2,AB3,AB4 | FDA listed | — |
| Levothyroxine sodium 25 ug 87063-0083-00 | ASCLEMED | 1000 tablets | — | AB1,AB2,AB3,AB4 | FDA listed | — |
| Levothyroxine .025 mgthis 87448-1502-03 | Northwestern | 1 tablet | — | AB1,AB2,AB3 | Discontinued | — |
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
🏛️
2019
On the market since
Jan 2019
📍
2026
Currently FDA-listed
7 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Oct 3, 2026
What it looks like
Color
orange
ShapeRound
ImprintL15
Size6 mm
ScoringScored — splits in 2
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
- FDA label on DailyMed · label index refreshed Oct 8, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Levothyroxine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
A current SPL was checked, but it does not contain a structured or narrative inactive-ingredient list for this product. This does not mean the product has no inactive ingredients.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Oct 8, 2026
- FDA openFDA NDC Directory · synced Oct 8, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerNorthwestern Memorial HealthCare
Application holderLUPIN INC
FDA applicationANDA209713 (ANDA)
Labeler code87448
First marketedJan 2019
Product typeHuman Prescription Drug
Portfolio5 products on file
More NDCs from Northwestern Memorial HealthCare labeler code 87448
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- Drugs@FDA
Full prescribing information FDA SPL
The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📦 How Supplied / Storage and Handling ▾
HOW SUPPLIED Levothyroxine sodium tablets USP are round, colored, scored and debossed with following debossing details on one side and break-line on other side. Strength (mcg): 25 Color/Shape: Peach/Round Debossing Details: L15 NDC# for bottles of 90: 68180-965-09 NDC # for bottles of 100: 68180-965-01 NDC # for bottles of 1000: 6810-965-03
📄 Package Label / Principal Display Panel ▾
Levothyroxine 25mcg tab
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Levothyroxine — the ingredient across all brands.
Top reported reactions
Reporter sex
Male · 19%
Female · 81%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
About this NDC listing & data coverage
Finished prescription product
No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | ✓ Available |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Who lists this product with the FDA?
Northwestern Memorial HealthCare is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.